Anti-HPV16 L2 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22358; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our highly efficient Anti-HPV16 L2 Polyclonal Antibody, a powerful tool for your biotech research needs. This antibody targets the L2 protein of the human papillomavirus type 16 (HPV16), a known cause of cervical cancer and other HPV-related diseases.
The Anti-HPV16 L2 Polyclonal Antibody is specifically designed to bind to the L2 protein of HPV16, inhibiting its function and preventing viral infection. This antibody is able to recognize and neutralize multiple strains of HPV16, making it a valuable tool for studying the virus and developing potential treatments.
This antibody is ideal for use in various research applications, including immunohistochemistry, western blotting, and flow cytometry. It can also be used in viral neutralization assays to assess the efficacy of potential antiviral drugs.
The Anti-HPV16 L2 Polyclonal Antibody has been successfully used in several experimental studies. In one study, it was used to identify the presence of HPV16 in cervical cancer cells, providing valuable insights into the role of the virus in cancer development. In another study, this antibody was used to assess the effectiveness of a novel vaccine against HPV16, demonstrating its potential as a research tool for vaccine development.
With its high specificity and sensitivity, our Anti-HPV16 L2 Polyclonal Antibody is an essential tool for any biotech researcher studying HPV16 and its associated diseases. Its ability to target multiple strains of the virus and its versatility in various applications make it a valuable asset in the fight against HPV-related diseases.
Don’t miss out on the opportunity to advance your research with our Anti-HPV16 L2 Polyclonal Antibody. Order now and take a step closer to understanding and combating HPV16.
ProteoGenix catalogue number ARO-A22358. For research use only.
Target: Minor capsid protein L2, L2; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Minor capsid protein L2, L2 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
